MetLife Investment Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$276K	Hold	34,338	–	–	﹤0.01%	2053
2025 Q4	$400K	Hold	34,338	–	–	﹤0.01%	1897
2025 Q3	$345K	Buy	34,338 +1,561	+5%	+$22.4K	﹤0.01%	2001
2025 Q2	$572K	Buy	32,777 +342	+1%	+$4.93K	﹤0.01%	1611
2025 Q1	$408K	Sell	32,435 -651	-2%	-$7.83K	﹤0.01%	1820
2024 Q4	$349K	Buy	33,086 +3,769	+13%	+$52.8K	﹤0.01%	1990
2024 Q3	$425K	Hold	29,317	–	–	﹤0.01%	1865
2024 Q2	$249K	Buy	29,317 +15,533	+113%	+$138K	﹤0.01%	2110
2024 Q1	$141K	Hold	13,784	–	–	﹤0.01%	2374
2023 Q4	$75.5K	Hold	13,784	–	–	﹤0.01%	2715
2023 Q3	$52.1K	Hold	13,784	–	–	﹤0.01%	2825
2023 Q2	$92.4K	Buy	+13,784	New	+$92K	﹤0.01%	2725
2021 Q4	–	Sell	-9,098	Closed	-$90.8K	–	2549
2021 Q3	$90.8K	Buy	9,098 +3,571	+65%	+$88.1K	﹤0.01%	2478
2021 Q2	$171K	Hold	5,527	–	–	﹤0.01%	2250
2021 Q1	$241K	Buy	+5,527	New	+$262K	﹤0.01%	1954